Form S-1/A Silexion Therapeutics
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250114/A5Z2V22CZ22FD2W2222Q2CZ29U9D3Z2I3272
Filed on: January 14, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Csquare prices IPO at $21 per share on NYSE
- Goldman Sachs Downgrades GQG Partners Inc (GQG:AU) to Sell
- Tailored Brands files for IPO, plans Nasdaq listing under MENW
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
